Phathom Pharmaceuticals, Inc. PHAT Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s change in AP?
- Phathom Pharmaceuticals, Inc. (PHAT) reported change in AP of -$3.12M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s change in AP changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s change in AP increased by 55.1% year-over-year, from -$6.96M to -$3.12M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s change in AP?
- Over 2 years (2022 to 2025), Phathom Pharmaceuticals, Inc.'s change in AP has grown at a 98.2% compound annual growth rate (CAGR), from $8.68M to $34.1M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.